Essential information for legal counsel and product development teams!
The Supreme Court’s decision in KSR v. Teleflex profoundly changed the landscape for biopharma companies and medical device manufacturers when it comes to building patent portfolios and managing them. More recently, the Federal Circuit’s Bilski decision in October 2008 added yet another dimension of complexity.
In this audio conference, we examine how this new environment changes the work of managers and professionals in product development teams, as well as patent professionals seeking to protect innovations. The presentation looks at how to identify and strengthen patents that might be vulnerable to obviousness attacks, and discusses ways to write and prosecute them to mitigate that risk.
Patent Portfolio Strategies in the Post-KSR Environment was presented by Bruce D. Sunstein, Co-Founder & Partner, Bromberg & Sunstein LLP and aired on 2009-02-12. For more details or to download this event, please visit our site at www.fxconferences.com
